Authors


Nicole Chase, MD, FAAP, FACAAI, FAAAAI

Latest:

Advice for Clinicians Managing Asthma

The panel offers their final recommendations for physicians managing patients with asthma.


Douglas Wolf, MD

Latest:

Exploring the Evolving Treatment Landscape for Inflammatory Bowel Disease

Expert gastroenterologists delve into the long-term management of Crohn’s disease and ulcerative colitis and examine the latest treatment options and strategies to enhance patient outcomes.


Victoria Johnson

Latest:

Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA

Findings from PsABIOnd can help reassure clinicians of similar efficacy between treatment choices.





Arun Jesudian, MD

Latest:

Refractory Encephalopathy, Multivitamins and Closing Thoughts

Medical experts share insights on managing refractory hepatic encephalopathy and provide concluding remarks and essential points on the condition.


Teena Chopra, MD, MPH

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Abby Reinhard

Latest:

The Expansion Toward Integrative Wellness Approaches in MS Care

Clinicians have begun to incorporate more holistic ways to approach the treatment of multiple sclerosis symptoms by focusing on better overall health, exercising, and dieting.


Paul S. Jellinger, MD, MACE

Latest:

Future Directions for the Treatment of ASCVD and Hypercholesterolemia

Drs Paul S. Jellinger, Erin D. Michos, Matthew J. Budoff, Christie Ballantyne, and Yehuda Handelsman share closing thoughts and advice for the management of ASCVD and hypercholesterolemia.


Kristin Sokol, MD

Latest:

Future Landscape of BTK Inhibitors for CSU

Panelists discuss the current and future roles of advanced treatments, including biologics and Bruton tyrosine kinase (BTK) inhibitors, in the management of chronic spontaneous urticaria (CSU), highlighting their potential to improve patient outcomes and the evolving landscape of treatment options.


Michael Feld, MD

Latest:

Final Thoughts on Management of ADHD

ADHD experts share their final thoughts on the treatment and management of ADHD.


Davida Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health System

Latest:

Final Thoughts: Awareness and Communication in Diabetes

Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers. 


Nathaniel F. Watson, MD

Latest:

Resources for Sleep Disorders

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.


Anne Peters, MD, Keck School of Medicine of the University of Southern California

Latest:

Final Thoughts: Awareness and Communication in Diabetes

Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers. 


Nehad Soloman, MD, FACR

Latest:

Moving Beyond the Joint: The Interplay Between Gout and Kidney Disease

Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.


Peter Lio, MD

Latest:

Future Outlook for Atopic Dermatitis Treatments

Medical experts share their final thoughts on the future of atopic dermatitis treatment with oral systemic agents.


Chari Cohen, DrPH, MPH | Credit LinkedIn
Chari Cohen, DrPH, MPH

Latest:

Role of Advocacy, Patient Voice in Hepatitis B

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the role of advocacy and patient voice in HBV management.


Lisa Swanson, MD, PhD

Latest:

Clinical Pearls for the Treatment of AD

Expert dermatologists share clinical pearls for providers treating patients with AD, and discuss the future of AD treatment.


Matt Feldman, MD

Latest:

Key Takeaways on the Optimal Management of Atopic Dermatitis

Closing out their discussion on the management of atopic dermatitis, expert panelists share clinical pearls and key takeaways from their discussion.


Kendall Donaldson, MD, MS

Latest:

Emerging Treatments for Dry Eye Disease

Ophthalmologist experts provide an overview of emerging treatments for dry eye disease.


Hanford Yau, MD

Latest:

Long-Term Outcomes for Patients Treated for Hypercortisolism

The panel concludes by discussing the long-term outcomes for patients treated for hypercortisolism, emphasizing the need for further studies and data, and sharing their final thoughts on the disease and its future management.



Palak Trivedi, MD, PhD | Credit Uni of Birmingham
Palak Trivedi, MD, PhD

Latest:

The Future of PBC Management, Pipeline Developments

In this video segment, Reau, Trivedi, and Hirschfield discuss pipeline developments and other advances in primary biliary cholangitis they are most looking forward to.


Diana Castro, MD, Children’s Heath UT Southwestern

Latest:

Advice to Community Pediatricians Evaluating SMA

Closing thoughts on advice to community pediatricians evaluating a baby for spinal muscular atrophy (SMA).


Chiara Maruggi, MD

Latest:

The Clinical Challenge of Seronegative Villous Atrophy: A Preview

Findings suggest a heterogeneous makeup of seronegative enteropathies, presenting difficulty in diagnosing patients with villous atrophy and negative celiac serologic testing.


Marla Dubinsky, MD

Latest:

Selecting CD Treatment in Special Scenarios

Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.



Darren West, MPAS, PA-C

Latest:

Clinical Pearls and Educational Needs in Plaque Psoriasis

Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.


© 2024 MJH Life Sciences

All rights reserved.